Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Orlistat market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period.
This report presents the market size and development trends by detailing the Orlistat market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Orlistat market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Orlistat industry and will help you to build a panoramic view of the industrial development.
Orlistat Market, By Type:
120mg
60mg
Orlistat Market, By Application:
Weight-reducing Aid
Other
Some of the leading players are as follows:
ZEIN pharmaceutical
Lunan Pharmaceutical Group Corporation
STADA-VN JVCo, Ltd
DM Pharma
STADA-VN J.V.Co., Ltd
Sandoz(Novartis)
China Zhongshan Pharm
Kabir Life Sciences & Research
Hexal AG
Teva
GSK group
Roche
HISUN
National Company for Pharmaceutical Industry
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Orlistat Market: Technology Type Analysis
-
4.1 Orlistat Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Orlistat Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 120mg
4.3.2 60mg
5 Orlistat Market: Product Analysis
-
5.1 Orlistat Product Market Share Analysis, 2018 & 2026
-
5.2 Orlistat Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Orlistat Market: Application Analysis
-
6.1 Orlistat Application Market Share Analysis, 2018 & 2026
-
6.2 Orlistat Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Weight-reducing Aid
6.3.2 Other
7 Orlistat Market: Regional Analysis
-
7.1 Orlistat Regional Market Share Analysis, 2018 & 2026
-
7.2 Orlistat Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 ZEIN pharmaceutical
9.1.1 ZEIN pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Lunan Pharmaceutical Group Corporation
9.2.1 Lunan Pharmaceutical Group Corporation Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 STADA-VN JVCo, Ltd
9.3.1 STADA-VN JVCo, Ltd Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 DM Pharma
9.4.1 DM Pharma Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 STADA-VN J.V.Co., Ltd
9.5.1 STADA-VN J.V.Co., Ltd Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Sandoz(Novartis)
9.6.1 Sandoz(Novartis) Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 China Zhongshan Pharm
9.7.1 China Zhongshan Pharm Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Kabir Life Sciences & Research
9.8.1 Kabir Life Sciences & Research Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Hexal AG
9.9.1 Hexal AG Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Teva
9.10.1 Teva Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 GSK group
9.11.1 GSK group Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Roche
9.12.1 Roche Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 HISUN
9.13.1 HISUN Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 National Company for Pharmaceutical Industry
9.14.1 National Company for Pharmaceutical Industry Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 104 Figures and 133 Tables)
Figure 120mg Orlistat market, 2015 - 2026 (USD Million)
Figure 60mg Orlistat market, 2015 - 2026 (USD Million)
Figure Weight-reducing Aid market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Orlistat market, by country, 2015 - 2026 (USD Million)
-
Table North America Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table North America Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table North America Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Canada Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Canada Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Europe Orlistat market, by country, 2015 - 2026 (USD Million)
-
Table Europe Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Europe Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Europe Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Germany Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Germany Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table France Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table France Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Italy Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Italy Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Spain Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Spain Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Orlistat market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table China Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table China Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Japan Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Japan Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table India Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table India Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Orlistat market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table MEA Orlistat market, by country, 2015 - 2026 (USD Million)
-
Table MEA Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table MEA Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table MEA Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Orlistat market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Orlistat market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Orlistat market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table ZEIN pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lunan Pharmaceutical Group Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table STADA-VN JVCo, Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DM Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table STADA-VN J.V.Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sandoz(Novartis) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table China Zhongshan Pharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kabir Life Sciences & Research Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hexal AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table HISUN Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table National Company for Pharmaceutical Industry Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
